Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01158976 · ClinicalTrials.gov registry record · NA
Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT01158976: Completed NA study, sponsored by University of Chicago.
NCT01158976 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01158976, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
This will be the first study of the effect of essential fatty acid supplementation in pregnant women living in inner-city poverty on the stress response system during pregnancy. The investigators proposed that essential fatty acid supplementation will be associated with reductions in the experience of stress, more modulated hormonal response to stress, and more optimal regulation of emotion and attention in the infant, even within the context inner-city poverty.
Primary Outcome
Maternal stress regulation at 30 weeks gestation
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Docosahexanoic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01158976 record still lists
NCT01158976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01158976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01158976 about?
NCT01158976 is a clinical study titled "Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress". This will be the first study of the effect of essential fatty acid supplementation in pregnant women living in inner-city poverty on the stress response system during pregnancy. The investigators proposed that essential fatty acid supplementation will be associated with reductions in the experience ...
What is the current status of trial NCT01158976?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2009-12. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01158976?
The interventions under investigation include: Placebo (OTHER), Docosahexanoic Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01158976?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01158976's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia